Integrative multi-omics, machine learning, computational toxicology, and experimental validation reveal PFAS-associated immune–inflammatory signatures in chronic obstructive pulmonary disease
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: The study combined PFAS-associated targets, COPD transcriptomics and 113 machine-learning model combinations to prioritize HMOX1, JUNB, CXCL12 and PTGS2. Exploratory plasma ELISA supported higher levels of the candidate proteins in COPD participants; the authors state that exposure causality is not established.
Technology: Multi-omics and machine-learning prioritization of PFAS-associated COPD molecular candidates
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- A combination of 113 machine-learning pipelines prioritized candidate genes from PFAS target information and COPD expression data; experimental and patient-sample measurements were used to examine the selected candidates.
- Limitation / still unknown
- The study evaluates the reported models and datasets only; broader generalization and real-world deployment outcomes were not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1965629/full
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.